ACTICAM 2.5MG CHEWABLE TABLETS FOR DOGS
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
21-11-2015
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
MELOXICAM
Available from:
Ecuphar NV
ATC code:
QM01AC06
INN (International Name):
MELOXICAM
Dosage:
2.5 Milligram
Pharmaceutical form:
Tablets Chewable
Prescription type:
POM
Therapeutic group:
Canine
Therapeutic area:
Meloxicam
Therapeutic indications:
N.S.A.I.D
Authorization status:
Authorised
Authorization date:
2011-01-28
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Acticam 2.5mg Chewable Tablets for Dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each chewable tablet contains:
ACTIVE SUBSTANCE:
Meloxicam
2.5 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Chewable tablets
Light lemon yellow, honey flavoured, round, biconvex, uncoated tablet, debossed with 'M2' on either side of breakline
on one side and plain on other side.
The tablet can be divided into two equal parts.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.
4.3 CONTRAINDICATIONS
Do not use in pregnant or lactating animals.
Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic,
cardiac or renal function and haemorrhagic disorders.
Do not use in dogs less than 6 weeks of age or less than 10 kg body weight.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 06/11/2015_
_CRN 7020051_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity.
This product for dogs should not be used in cats as it is not suitable for use in this species.
SPECIAL PRECAUTIONS TO BE TAKEN BY T
Read the complete document
